Cardiovascular & Hematological Agents in Medicinal Chemistry
Title:Meet our Editorial Board Member
Volume: 14 Issue: 2
Author(s): Michele Correale
Affiliation:
Export Options
About this article
Cite this article as:
Correale Michele, Meet our Editorial Board Member, Cardiovascular & Hematological Agents in Medicinal Chemistry 2016; 14 (2) . https://dx.doi.org/10.2174/187152571402170118225517
DOI https://dx.doi.org/10.2174/187152571402170118225517 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Current Drug Targets Recent Avenues in Novel Patient-Friendly Techniques for the Treatment of Diabetes
Current Drug Delivery CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of Meglitinides
Current Drug Safety Novel Monocyte Biomarkers of Atherogenic Conditions
Current Pharmaceutical Design New Insights on the Impact of Statin Therapy in the Susceptibility to Hypovitaminosis D Through Serum Lipidome Profiling
Cardiovascular & Hematological Agents in Medicinal Chemistry Humanin; A Defender Against Alzheimers Disease?
Recent Patents on CNS Drug Discovery (Discontinued) UR-3216: A New Generation Oral Platelet GPIIb / IIIa Antagonist
Current Pharmaceutical Design Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Recent Patents on Cardiovascular Drug Discovery The Future of Collateral Artery Research
Current Cardiology Reviews Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review
Current Drug Targets Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors
Current Pharmaceutical Design Cutting through the Complexities of mTOR for the Treatment of Stroke
Current Neurovascular Research The Effect of Lead Exposure on Selected Blood Inflammatory Biomarkers in Guinea pigs
Cardiovascular & Hematological Disorders-Drug Targets Single Molecule Techniques for Biomedicine and Pharmacology
Current Pharmaceutical Biotechnology In Vivo Cellular Imaging for Translational Medical Research
Current Medical Imaging The Potential Role of Angiotensin Converting Enzyme and Vasopeptidase Inhibitors in the Treatment of Diabetic Neuropathy
Current Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) PEGylation: a successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease
Protein & Peptide Letters